Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice
Open Access
- 28 February 2018
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2018, 1-8
Abstract
Norovirus (NoV) is a main cause of acute gastroenteritis across all ages worldwide. NoV vaccine candidates currently in clinical trials are based on noninfectious highly immunogenic virus-like particles (VLPs) delivered intramuscularly (IM). Since NoV is an enteric pathogen, it is likely that mucosal immunity has a significant role in protection from infection in the intestine. Due to the fact that IM delivery of NoV VLPs does not generate mucosal immunity, we investigated whether NoV genotype GII.4 VLPs coadministered with aluminum hydroxide (Al(OH)3) or monophosphoryl lipid A (MPLA) would induce mucosal antibodies in mice. Systemic as well as mucosal IgG and IgA antibodies in serum and intestinal and nasal secretions were measured. As expected, strong serum IgG, IgG1, and IgG2a antibodies as well as a dose sparing effect were induced by both Al(OH)3and MPLA, but no mucosal IgA antibodies were detected. In contrast, IN immunization with GII.4 VLPs without an adjuvant induced systemic as well as mucosal IgA antibody response. These results indicate that mucosal delivery of NoV VLPs is needed for induction of mucosal responses.Keywords
This publication has 39 references indexed in Scilit:
- Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in MicePLOS ONE, 2013
- Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitroImmunology Letters, 2012
- Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus ChallengePLOS Pathogens, 2012
- Norovirus Vaccine against Experimental Human Norwalk Virus IllnessNew England Journal of Medicine, 2011
- A comparison of immunogenicity of norovirus GII‐4 virus‐like particles and P‐particlesImmunology, 2011
- A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particlesArchives of Virology, 2010
- Systematic Literature Review of Role of Noroviruses in Sporadic GastroenteritisEmerging Infectious Diseases, 2008
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvantCellular and Molecular Life Sciences, 2008
- TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccinesVaccine, 2008
- Immune responses to bovine norovirus-like particles with various adjuvants and analysis of protection in gnotobiotic calvesVaccine, 2006